Friday, May 24, 2019 10:14:25 PM
Recent RGNX News
- REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2024 Financial Results and Recent Operational Highlights • PR Newswire (US) • 10/30/2024 11:05:00 AM
- REGENXBIO Presents Positive Data from the Phase II Study of Subretinal ABBV-RGX-314 in Patients with Bilateral Wet AMD at AAO 2024 • PR Newswire (US) • 10/21/2024 11:05:00 AM
- REGENXBIO Announces Presentations at the American Academy of Ophthalmology 2024 Annual Meeting • PR Newswire (US) • 10/18/2024 11:05:00 AM
- REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines Conference • PR Newswire (US) • 09/23/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 09:04:24 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 09:03:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 09:00:23 PM
- REGENXBIO Appoints Mitchell Chan as Chief Financial Officer • PR Newswire (US) • 09/17/2024 11:05:00 AM
- REGENXBIO Announces Positive Data from Pivotal Dose Level of RGX-121 Demonstrating Long-Term Systemic Effect • PR Newswire (US) • 09/03/2024 12:04:00 PM
- REGENXBIO to Participate in Upcoming Investor Conferences • PR Newswire (US) • 08/29/2024 08:05:00 PM
- REGENXBIO Announces Presentation at the Society for the Study of Inborn Errors of Metabolism (SSIEM) 2024 Annual Symposium • PR Newswire (US) • 08/27/2024 11:05:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 08:58:45 PM
- REGENXBIO to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference • PR Newswire (US) • 08/08/2024 11:05:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 10:41:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 10:38:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:20:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:10:10 PM
- REGENXBIO Reports Second Quarter 2024 Financial Results and Recent Operational Highlights • PR Newswire (US) • 08/01/2024 08:05:00 PM
- REGENXBIO ANNOUNCES NEW POSITIVE DATA FROM AFFINITY DUCHENNE® TRIAL OF RGX-202 • PR Newswire (US) • 08/01/2024 11:03:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 09:00:10 PM
- REGENXBIO to Host Conference Call on August 1 to Discuss Second Quarter 2024 Financial Results and Recent Operational Highlights • PR Newswire (US) • 07/25/2024 11:05:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2024 09:05:11 PM
- REGENXBIO Announces Expansion of AFFINITY DUCHENNE® Trial to Include a New Cohort of Younger Patients • PR Newswire (US) • 06/24/2024 11:05:00 AM
- REGENXBIO Announces Successful Pre-BLA Meeting with FDA to Support Accelerated Approval Pathway for RGX-121 for the Treatment of MPS II • PR Newswire (US) • 06/18/2024 11:05:00 AM
- REGENXBIO Announces Leadership Transition • PR Newswire (US) • 06/12/2024 11:05:00 AM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM